2-(4-ethylanilino)-N,N-dimethyl-1-[(1R,5R)-3,3,5-trimethylcyclohexyl]benzimidazole-5-carboxamide
C27H36N4O — CID 118318513
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(4-ethylanilino)-N,N-dimethyl-1-[(1R,5R)-3,3,5-trimethylcyclohexyl]benzimidazole-5-carboxamide
2-(4-ethylanilino)-N,N-dimethyl-1-[(1R,5R)-3,3,5-trimethylcyclohexyl]benzimidazole-5-carboxamide (PubChem CID 118318513) has the molecular formula C27H36N4O and a molecular weight of 432.61 g/mol. Its IUPAC name is 2-(4-ethylanilino)-N,N-dimethyl-1-[(1R,5R)-3,3,5-trimethylcyclohexyl]benzimidazole-5-carboxamide.
Molecular Properties
| Compound Name | 2-(4-ethylanilino)-N,N-dimethyl-1-[(1R,5R)-3,3,5-trimethylcyclohexyl]benzimidazole-5-carboxamide |
|---|---|
| PubChem CID | 118318513 |
| Molecular Formula | C27H36N4O |
| Molecular Weight | 432.61 g/mol |
| Exact Mass | 432.29 |
| IUPAC Name | 2-(4-ethylanilino)-N,N-dimethyl-1-[(1R,5R)-3,3,5-trimethylcyclohexyl]benzimidazole-5-carboxamide |
| SMILES | CCc1ccc(Nc2nc3cc(C(=O)N(C)C)ccc3n2[C@@H]2C[C@H](C)CC(C)(C)C2)cc1 |
| InChI | InChI=1S/C27H36N4O/c1-7-19-8-11-21(12-9-19)28-26-29-23-15-20(25(32)30(5)6)10-13-24(23)31(26)22-14-18(2)16-27(3,4)17-22/h8-13,15,18,22H,7,14,16-17H2,1-6H3,(H,28,29)/t18-,22+/m0/s1 |
| InChIKey | UUVRQFXUFLOILN-PGRDOPGGSA-N |
| XLogP | 6.43 |
| TPSA | 50.16 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 432.61 |
| LogP ≤ 5 | 6.43 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118318513 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.